Search research articles
Contact Us
Filters
Showing results (31-40 of 175) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1996
Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade
G Liu, M Crump, P E Goss, et al.
American Journal of Clinical Oncology
|
October 1, 1986
5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung
F A Shepherd, W K Evans, R Burkes, et al.
AIDS (London, England)
|
March 1, 1991
A phase II study of 4'-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS
F A Shepherd, R L Burkes, K E Paul, et al.
Seminars in Oncology
|
September 1, 1986
First-line therapy with VP-16 and cisplatin for small-cell lung cancer
W K Evans, F A Shepherd, R Feld, et al.
The Journal of Pathology
|
February 5, 2000
Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer
P Thomas, R Khokha, F A Shepherd, et al.
Cancer Treatment Reports
|
February 1, 1985
Phase II evaluation of bisantrene in patients with advanced non-small cell lung carcinoma
R Feld, W K Evans, F A Shepherd, et al.
Archives of Internal Medicine
|
May 1, 1984
Myasthenic syndrome and small cell cancer of the lung. Variable response to antineoplastic therapy
G H Clamon, W K Evans, F A Shepherd, et al.
Radiology
|
February 11, 1998
Lymphoproliferative disorders after lung transplantation: imaging features
D C Rappaport, D W Chamberlain, F A Shepherd, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 1, 1996
Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report
F A Shepherd, R Burkes, Y Cormier, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 6, 2013
An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib
J F Hilton, D Tu, L Seymour, et al.
Page
of 18
Search research articles
Search
Showing results (31-40 of 175) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1996
Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade
G Liu, M Crump, P E Goss, et al.
American Journal of Clinical Oncology
|
October 1, 1986
5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung
F A Shepherd, W K Evans, R Burkes, et al.
AIDS (London, England)
|
March 1, 1991
A phase II study of 4'-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS
F A Shepherd, R L Burkes, K E Paul, et al.
Seminars in Oncology
|
September 1, 1986
First-line therapy with VP-16 and cisplatin for small-cell lung cancer
W K Evans, F A Shepherd, R Feld, et al.
The Journal of Pathology
|
February 5, 2000
Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer
P Thomas, R Khokha, F A Shepherd, et al.
Cancer Treatment Reports
|
February 1, 1985
Phase II evaluation of bisantrene in patients with advanced non-small cell lung carcinoma
R Feld, W K Evans, F A Shepherd, et al.
Archives of Internal Medicine
|
May 1, 1984
Myasthenic syndrome and small cell cancer of the lung. Variable response to antineoplastic therapy
G H Clamon, W K Evans, F A Shepherd, et al.
Radiology
|
February 11, 1998
Lymphoproliferative disorders after lung transplantation: imaging features
D C Rappaport, D W Chamberlain, F A Shepherd, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 1, 1996
Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report
F A Shepherd, R Burkes, Y Cormier, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 6, 2013
An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib
J F Hilton, D Tu, L Seymour, et al.
Page
of 18